The Limb Salvage Center

Filter Your Results




Nationwide Cohort Study Evaluates Readmissions After Revascularization Procedures for PAD

December 6, 2017 -- In Annals of Internal Medicine, Eric A. Secemsky, MD, et al published findings online from a retrospective cohort study that sought to evaluate nationwide …

Cagent Vascular’s Serrantor Alto PTA Serration Balloon Catheter Receives CE Mark

November 21, 2017 -- Cagent Vascular announced that its Serranator Alto PTA serration balloon catheter has received CE Mark approval. The Serranator Alto, which received FD…

Trial Subanalysis Finds Empagliflozin Can Reduce Risk of Cardiovascular Death in Patients With Type 2 Diabetes and PAD

November 21, 2017 -- Data from the EMPA-REG OUTCOME trial showed that empagliflozin reduced the risk of cardiovascular death compared with placebo when added to standard of ca…

Single-Center TOBA Study’s 24-Month Results Presented for Intact Vascular's Tack Endovascular System

November 16, 2017 -- Intact Vascular, Inc. announced that positive single-center 24-month results from its Tack Optimized Balloon Angioplasty (TOBA) clinical study were presen…

Swedish Registry Evaluates Popliteal Artery Aneurysms in Women

November 15, 2017 -- Findings from a study on popliteal artery aneurysms in women were published by Hans Ravn, MD, et al online ahead of print in European Journal of Vascular …

Hemodynamic Assessment Before and After Endovascular Therapy for CLI Studied for Prognostic Value of Outcomes

November 15, 2017 -- Grant W. Reed, MD, et al published findings from a study on hemodynamic assessment before and after endovascular therapy for critical limb ischemia (…

Results Published From Cook Medical's Zilver PTX Japan Postmarket Surveillance Study

November 8, 2017 -- Results from the Zilver PTX Japan postmarket surveillance study of the Zilver PTX paclitaxel-eluting stent (Cook Medical) were published by Stefano Cipolla…

Enrollment Completed in the LIMBO-ATX Trial of Mercator's Bullfrog Device to Treat CLI

November 2, 2017 -- Mercator MedSystems, Inc. announced that enrollment has been completed for the company's LIMBO-ATX clinical trial. According to the company, the LIM…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.